| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Opus Genetics, Inc. (IRD) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. IRD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.79M | $14.11M | - | |
| ? | 1.99M | $7.41M | - | |
| CEO | 1.73M | $6.44M | -9,475 | |
| Pres | 704.1K | $2.62M | -7,429 | |
| CFO | 584.4K | $2.17M | -7,783 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2021 | Benton Susan | Director | Buy | 20,000 | $4.57 | $91,400.00 | +503.0% | -20.1% | -51.2% | |
| Nov 19, 2020 | Meyer Alan R | Director | Buy | 1,771 | $0.00 | - | +0.4% | - | - | |
| Nov 19, 2020 | Sooch Mina | President And CEO | Buy | 11,524 | $0.00 | - | +1.5% | - | - | |
| Nov 19, 2020 | Gallagher Cam81 | Director | Buy | 8,865 | $0.00 | - | +61.2% | - | - | |
| Nov 19, 2020 | Rodgers Richard J | Director | Buy | 17,730 | $0.00 | - | +300.0% | - | - | |
| Nov 19, 2020 | Manuso James S J | Director | Buy | 4,434 | $0.00 | - | +43.7% | - | - | |
| Nov 19, 2020 | Ainsworth Sean | Director | Buy | 8,865 | $0.00 | - | +24.8% | - | - | |
| Jan 31, 2019 | Beever Charles | Director | Buy | 10,000 | $0.64 | $6,380.00 | +1,000% | - | - | |
| Jan 30, 2019 | Nolan Lisa | Chief Business Officer | Buy | 20,000 | $0.65 | $12,960.00 | +1,231% | - | - | |
| Jan 29, 2019 | Swirsky Douglas J | President And CEO | Buy | 50,000 | $0.63 | $31,720.00 | New | - | - |